Evaluation of the Salivary Flow in Patients with Schizophrenia. A Literature Review

Schizophrenia is a chronic psychiatric disease that affects approximately 1% of the global population. characterised by positive, negative and cognitive symptoms. The etiological factors this illness are not fully deciphered, but most incriminated genetic environmental risk factors.
 treatment schizophrenia has role reduction duration intensity episodes consists in administration typical or atypical antipsychotic drugs, antiparkinsonian, anxiolytic, sedatives antidepressants. Of these, some drugs may have side effects modify patients' salivary flow rates.
 Xerostomy subjective sign characterized dry mouth sensation caused hypofunction glands. According to series studies, xerostomia can be an adverse effect medication as well antiparkinsonian medication. Sialorrhea hyperfunction glands increased secretion saliva. This especially noticeable during night sleep. Alteration function creates discomfort schizophrenic patient, which causes him give up regular medication.
 aim study review literature on link between schizophrenia, impaired function.